Today’s Market Takeaways: May 21, 2021

Today’s Market Takeaways: June 8, 2021

June 8, 2021

The FDA approved a new Alzheimer’s drug for the first time in nearly 20 years, but it’s not without some controversy. Research Analyst Liz Laprade explains the implications for the health care and biotech sectors in Today’s Market Takeaways. If you have questions for Liz, please send them to

85 Wells Avenue, Suite 109
Newton, MA, 02459

© 2021 Adviser Investments, LLC

Adviser Investments' logo is a registered trademark of Adviser Investments, LLC.